The new name for - PowerPoint PPT Presentation

1 / 54
About This Presentation
Title:

The new name for

Description:

Widely used, especially in trading floors and corporate lending ... models for setting regulatory requirements on trading book, since 1996 ... trading ... – PowerPoint PPT presentation

Number of Views:38
Avg rating:3.0/5.0
Slides: 55
Provided by: justi131
Category:

less

Transcript and Presenter's Notes

Title: The new name for


1
Alistair Milne Cass Business School amilne_at_city.ac
.uk Risk Management in Insurance and
Insolvency, The Hebrew University of
Jerusalem, October 16th-17th 2006
2
Economic and Regulatory Capital Applications
in Banking and Lessons for the Insurance Industry
Alistair MilneCass Business School

3
My research focus
  • bank capital and shareholder value
  • i.e. risk-management and corporate finance
  • co-authors and papers
  • Giles and Milne (2004)
  • Dimou, Lawrence, and Milne (2005)
  • Milne and Onorato (2006a,2006b)
  • Milne (2006) Three lessons
  • theory informed by extensive interaction with
    practitioners

4
Agenda for today
  • The rise of bank risk management
  • bank economic capital current practice
  • A critique of this thinking
  • Practical issues
  • Cost of regulatory capital requirements
  • Skewness
  • Two proposed performance measures
  • Implications for insurance industry

5
Rise of bank risk-management
6
Greater competition
  • Core business (retail deposits, lending to
    households and smaller
    business) remains profitable but
  • Narrower margins in many markets
  • Especially corporate sovereign
  • New products creating exposure to
    market risks

7
Governance centre stage
  • Larger, more complex, institutions
  • Less state ownership or support more answerable
    to shareholders
  • Pressure to increase shareholder returns
  • Greater regulatory freedom in choice of
    activities
  • Regulatory oversight of risk-management

8
Databases and modelling
  • Cost of collecting, storing, and manipulating
    data fallen dramatically
  • New tools
  • Market risk VaR
  • Portfolio models of corporate and sovereign
    credit risks
  • Search for enterprise wide measures of risk/
    return e.g. pricing tools

9
Bank economic capitalcurrent practice
10
A new language
  • Capital
  • Capital as a measures of worst case exposure
  • Eg value at risk
  • Efficient allocation of this capital, to
    activities earning the highest return
  • Two birds with one stone
  • Solvency (enough capital) and
  • risk-reward tradeoffs (efficient allocation of
    capital)

11
RAROC
  • Standard formulation
  • Economic Capital value at risk type measure
    to cover all risks (market, credit, operational)
  • Accept when RAROC exceeds hurdle
  • Widely used, especially in trading floors and
    corporate lending

12
RAROC Logic
  • Equity capital to maintain AA rating, commonly
    99.97 on one year horizon
  • average AA default frequency
  • By assumption economic prudential
  • Equity capital is in limited supply
  • ration according to rate of return
  • Hurdle rate sometimes related to return on
    equity

13
Regulatory dimension
  • approved internal models for setting regulatory
    requirements on trading book, since 1996
  • Basel II aims to align regulatory and economic
    capital
  • Concerns about regulatory arbitrage
  • EU implementation 2007, delayed in US
  • IRB model based calculations of credit risk
  • not based on portfolio models, but asks banks to
    compute PD, LGD as inputs, and these could be
    derived from same databases as a portfolio model

14
A critique
15
A critique
  • Practical problems
  • Cost of regulatory capital?
  • Skewness
  • Conclusions use alternative performance measures,
    distinguish tail risks and risk-return tradeoffs

16
Competitive advantage?
  • Proposition 1 lower regulatory capital provides
    me with a competitive advantage
  • Proposition 2 estimating tail risks and
    allocating economic capital provides me with a
    competitive advantage
  • Both must be qualified
  • Competitive advantage of regulatory capital is
    small
  • Tail risks relatively unimportant to pricing
  • focus on value creation
  • Requires different metrics than RAROC

17
1. Some practical issues
18
Data problems credit risk
  • Larger corporates/ sovereigns fairly OK
  • CreditMetrics/MKMV
  • US ratings history back to 1950s or earlier
  • Difficulties with LGD
  • Retail (including smaller corporates)
  • a variety of scoring models, good for PD
  • a little work on CVaR
  • best UK institutions around 10-12 years data
  • UK FSA transitional arrangements accept 5 years
    of data for Basel computations! 2 years for LGD
  • Other low default portfolios,
  • even more severe data problems
  • Correlations?

19
Data problems op risk
  • Even greater than for credit risk
  • High frequency/ low impact
  • Most firms have databases, for a few years
  • Little comparability between firms
  • Mostly EL (minor contribution to EC)
  • Low frequency/ high impact
  • By their nature no data
  • Low correlation with market/ credit risks?

20
Outcome
  • lacking data we extrapolate
  • standard deviations, using arbitrary multipliers
  • PD as in Basel risk curves (Vasicek single factor
    model plus arbitrary correlation loading)
  • OP risk low frequency high impact, no
    statistical basis at all
  • We are confusing
  • Risk/return tradeoff (does not need extreme tail)
  • prudential safety (cannot be based on statistical
    models)

21
RAROC difficulty (1)
  • Liquidity facilities
  • eg Lines of credit to a AAA/AA corporates
  • eg commercial paper underwriting
  • Must back with capital
  • to maintain liquidity over (say) 24 months
  • Loss v. unlikely 99.97 appropriate
  • So VERY safe lending
  • 15 required return on this committed capital
    leads to unreasonably high pricing
  • Cannot compete with market prices

22
RAROC difficulty (2)
  • Capital in trading operations
  • Liquidity is lifeblood, need to survive
    temporary market fluctuations without being
    forced to close positions
  • Well known examples LTCM, Metallgesellschaft
  • Investors (shareholders) need to distinguish
    extreme tails and normal range of market
    fluctuations, only latter is priced risk

23
Back to basics
  • Ultimate objective shareholder value
  • Appropriate trade-offs between risk and reward
  • Protecting solvency of the institution
  • Incentives for employees and line management
  • Well developed tools for these tasks for
    non-financial companies
  • Net Present Value (NPV)
  • Economic Value Added
  • So lets apply these tools to banks

24
Some findings
  • Regulatory capital is NOT expensive
  • RAROC can be a misleading measure of returns to
    shareholders
  • In order to create shareholder value..
  • Distinguish capital management (liquidity,
    solvency) and risk-return tradeoffs
  • Modelling should take a back seat, to business
    application and organisational credibility

25
2. The cost of regulatory capital
26
Basic argument
  • WACC weighted average cost of capital
  • Sum of debt and equity components
  • Changing reg cap only small change WACC
  • linked to Modigliani-Miller (1958)
  • Detail (Milne and Giles (2004))
  • Equity capital small proportion of total funding
  • regulatory capital lt 11 impact on equity capital
  • e.g. if following rating agency target
  • Leverage adjustment
  • Higher equity capital makes equity capital less
    risky, lowers cost of equity

27
(No Transcript)
28
Cost of regulatory capital?
  • Even without leverage adjustment, regulatory
    capital not very expensive
  • WACC then yields an upper bound
  • Financial Services Authority calculations
  • eg Basel II, reduces reg cap by 10, worth at
    most 3 basis points on cost of funding your loan
    portfolio
  • Some implications
  • regulatory capital driven securitisation destroys
    shareholder value
  • Basel Pillar 1 calculations not of great business
    importance

29
Dimou, Lawrence, Milne (2005)
  • Increases tax exposure
  • higher equity capital reduces tax shield
  • a transfer a private but NOT a social cost
  • Reduces access to bank safety net
  • Higher equity capital forces bank owners to
    accept more risk
  • a transfer a private but NOT a social cost
  • Lowers expected costs of bankruptcy
  • Higher capital reduces probability of bankruptcy/
    financial distress
  • a benefit Social benefits likely to exceed
    private benefits.
  • Agency costs
  • Bank managers look after themselves, not
    shareholders
  • Equity capital gives managers freedom to pursue
    their own ends
  • Reg cap is different, it is a discipline on
    managers just like debt
  • neutral No private cost of reg cap, if not used
    as risk measure

30
3. Skewness
31
Theory
  • Proposition 1 (Onorato-Milne (2006))
  • Economic capital prudential capital
  • iff insurance cost of hedging risk w is
    proportional to prudential tail H-1(w)
  • Corollary
  • RAROC hurdle delivers shareholder value if all
    risk distributions have the same skew
  • Turnbull-Crouhy-Wakeman (1999) special case
  • Log normal asset returns so (right) skew
    increasing with s
  • As s rises, prudential tail rises less than
    insurance cost
  • So RAROC threshold rises with s

32
Illustrations
  • Taken from Milne and Onorato (2006a)
  • Apples and Pears? The comparison of bank
    economic and prudential capital.
  • Assume market price of risk proportional to
    standard deviation
  • Compare symmetric and right-tailed returns
  • What then is NPV0 hurdle rate for RAROC?

33
(No Transcript)
34
A credit risk distribution
  • Credit risk left skew
  • Vasicek asymptotic single factor model
  • Model used for Basel IRB risk curves
  • Left skew , so smaller NPV 0 RAROC
  • More detail on parameters
  • PD probability of default
  • ? correlation of credit risk driver with market
  • R2 correlation with aggregate (systematic) risk
  • How do these parameters affect RAROC hurdle?

35
(No Transcript)
36
Critique summarised
  • Two different objectives
  • Prudential (avoiding financial distress,
    satisfying regulator)
  • Risk-return tradeoffs
  • Using one measure of capital for both purposes
    creates conflicts
  • If tail risk is uncertain
  • If tail risk is skewed
  • If regulators take a conservative view of risks
  • Again does not matter to the business

37
Two proposed performance measures
38
Proposed measures
  • Milne and Onorato (2006a) discount with market
    based risk-premium f
  • Milne and Onorato (2006b) use Wang transform

39
More theory
  • Inventory models
  • Incorporate costs of financial distress, or
    penalty costs of raising capital
  • Froot and Stein (1998), Milne (2004)
  • Outcome additional internal beta G
  • Measures the risk of capital shortage
  • Depends upon
  • Probability of capital shortage
  • Costs of financial distress
  • For well capitalised bank, G can be ignored
  • Probability of capital shortage is negligible

40
Implication
  • Longer term equity capital not constrained
  • Retain earnings or rights issue
  • No need to ration, adjust to minimise WACC
  • Measuring NPV (shareholder value)
  • right WACC input
  • e.g. betas (cost of risk)
  • depend on correlation with market NOT with
    balance sheet
  • Equivalent to cost of insuring exposure
  • Capital constrained?
  • Additional cost of risk internal or portfolio
    beta G, for rationing capital

41
With market prices for risk
  • If risk can be priced on market, proceed as
    follows (Milne and Onorato (2006a))
  • Discount future returns with risk-premium taken
    from market prices
  • equivalently estimate the cost of hedging
    completely on the market and deduct this cost
    from expected return
  • (risk neutral pricing)
  • Divide by contribution to prudential capital
  • Hurdle rate? Zero if unconstrained. Otherwise
    chosen to ration equity capital

42
No market prices for risk
  • Use distortion measure (Milne and Onorato
    (2006b )) eg Wang transform
  • Portfolio based
  • Satisfies axioms of coherence and second order
    stochastic dominance
  • Divide by contribution to prudential capital
  • Hurdle rate? Zero if unconstrained. Otherwise
    chosen to ration equity capital

43
Merits of Wang transform
  • Yields an expected value
  • Analagous to risk neutral pricing distort
    the probability density of returns
  • risk appetive can be parameterized using a
    single parameter p

44
In practice very limited data
  • Especially for tail risks
  • Sophisticated modellign of tail risks not ormally
    appropraite
  • Simple stress or scenario analysis
  • Aim to achieve credibility, within the
    organisation and also with shareholders.

45
Implications for insurance
  • Some preliminary thoughts open to discussion
  • First general insurance, then life

46
When re-insurance markets available
  • Logic of Milne and Onorato (2006a) applies.
  • Price risk according to what it would cost to
    transfer onto re-insurance market deduct from
    premium income
  • Set a hurdle rate cost of equity capital
  • Zero if unconstrained, gt zero if rationing

47
When reinsurance limited
  • Use of the Wang transform can help systematise
    thinking about risk-appetite
  • Needs to be supplemented by e.g. stressed
    scenarios, to check capital adequacy

48
Data sometimes available
  • For some products extensive data available
  • Also the products where reinsurance markets are
    most liquidy
  • Models can be used for computing capital, but
    pricing best done off the market
  • For other products, very limited data and
    illiquid markets for re-insurance.
  • Here focus on the simplest possible modelling
    tools

49
One difference insurance and banking -
segmentation
  • Banks all seek to maintain high credit ratings
  • Some insurers may opt for lower capitalisation,
    and lower premium pricing to customers, with the
    understanding that they may fail in the event of
    a large aggregate rise in claims
  • Customers carry aggregate tail risks
  • Other insurers may choose high capitalisation,
    high pricing

50
Life insurance
  • Very long term mortality risks
  • No possibility of precise quanitification
  • Operate with conservative capitalisation
  • Should not restrict business, provided need for
    capital is understood by sharholders

51
Summary
52
I have discussed
  • The rise of bank risk management
  • bank economic capital current practice
  • A critique of this thinking
  • Practical issues
  • Cost of regulatory capital requirements
  • Skewness
  • Two proposed performance measures
  • Implications for insurance industry

53
Some findings
  • Regulatory capital is NOT expensive
  • RAROC can be a misleading measure of returns to
    shareholders
  • In order to create shareholder value..
  • Distinguish capital management (liquidity,
    solvency) and risk-return tradeoffs
  • Modelling should take a back seat, to business
    application and credibility in the organisation
  • Similar issues in insurance no problem with
    conservative capitalisation

54
Priority better risk language
  • Simple enough to be understood throughout the
    organisation
  • Key concepts
  • Balance sheet commitment and liquidity
  • Not a pricing issue
  • Expected loss
  • Cost of carrying risk
  • What reward do shareholders require for holding
    risk?
  • Use models where appropriate (market risk,
    corporate credit risk, retail insurance)
Write a Comment
User Comments (0)
About PowerShow.com